- Home
- Clinical Trials
- Trial for patients with Atrial fibrillation that cannot take anti-coagulants
Trial for patients with Atrial fibrillation that cannot take anti-coagulants
- Trial ID:
- IRB-17-6969
- Matthew J Price, M.D.
Inclusion Criteria
- Have documented paroxysmal, persistent, permanent or longterm persistent non-valvular atrial fibrillation
- Be deemed by two study physicians to be unsuitable for oral anticoagulation therapy
- Meet all other eligibility criteria
Exclusion Criteria
- Have been diagnosed with rheumatic mitral valvular heart disease
- Be planning to have any surgical procedure
- Have an implanted mechanical valve prosthesis in any position.
- Have New York Heart Association Class IV Congestive Heart Failure.
Additional Info
- The WATCHMAN device will be compared to standard of care. Eligible patients will have 50/50 chance of being randomized, like the flip of a coin, to receive the WATCHMAN device or continued medical management.
Contact Info:
- Heather Catchpole
- catchpole.heather@scrippshealth.org
- 858-824-4248